Oral zinc sulphate in recalcitrant multiple viral warts: A pilot study

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 6, 2009, Pages 715-716

  Sadighha, A ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ZINC; ZINC SULFATE;

ADOLESCENT; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VERRUCA VULGARIS; ZINC BLOOD LEVEL;

ADMINISTRATION, ORAL; HUMANS; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; WARTS; ZINC SULFATE;

EID: 67649723512     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03169.x     Document Type: Letter

References (3)

1. Gibbs S, Harvey I, Sterling J. Local treatment for cutaneous warts: systemic review. BMJ 2002 325 : 461 464. (Pubitemid 34983413)
2. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002 146 : 423 431. (Pubitemid 34603814)
3. Parton AM, Sommerville RG. The treatment of plantar verrucae by triggering cell-mediated immunity. J Br Pobmed 1994 49 : 205 209.